Vaccines and immunisation

Moderna to build UK’s first mRNA vaccine research and manufacturing centre

Boston-based biotech firm agrees £1bn deal with government for centre to combat Covid and other illnesses The Boston-based biotech Moderna is to build the UK’s first research and manufacturing centre dedicated to the development of mRNA vaccines against new Covid variants and other respiratory illnesses, in an effort to improve readiness for future pandemics. Under …

Moderna to build UK’s first mRNA vaccine research and manufacturing centre Read More »

The WTO faces a make or break week over vaccines | Larry Elliott

A ruling on whether or not to waive patent rules will this week show if the trade body is for the world or the west A crisis at the World Trade Organization has been brewing for years and it now looks like coming to a head. There are many potential flash points as trade ministers …

The WTO faces a make or break week over vaccines | Larry Elliott Read More »

Trials of new Covid vaccine raise hopes of once-a-year booster

Moderna shot is said to produce eightfold increase in antibody levels against Omicron in first four weeks An updated version of Moderna’s Covid vaccine produces an eightfold increase in antibody levels against the Omicron variant, according to early trial results, raising hopes for a once-a-year booster to protect against the disease. The vaccine is the …

Trials of new Covid vaccine raise hopes of once-a-year booster Read More »

Vaccine to stop Covid transmission should now be top priority, says leading UK scientist

Oxford University’s Sir John Bell says sharp fall in death rate due to existing vaccines allows for a change in priorities It is questionable how much longer current Covid-19 vaccines will be used as they have largely done their job in preventing mass deaths, and scientists should focus on developing a vaccine that stops transmission …

Vaccine to stop Covid transmission should now be top priority, says leading UK scientist Read More »

Hopes rise for Covid vaccine patent waiver after key countries agree on proposal

The proposal, if passed by the full council, could allow other countries to make vaccines without paying pharmaceutical companies The World Trade Organization’s (WTO) most powerful members said on Tuesday that they had agreed on a proposed waiver on intellectual property rights for Covid-19 vaccines in the hopes of speeding up rollouts worldwide. The proposal …

Hopes rise for Covid vaccine patent waiver after key countries agree on proposal Read More »

AstraZeneca boss calls for UK to provide new Covid-19 medicine to the vulnerable

Pharmaceutical CEO says it’s ‘sad’ that UK has failed to order Evusheld for the immunosuppressed AstraZeneca boss Pascal Soriot has called on the government to provide access to its Covid-19 medicine Evusheld, saying it’s a “sad situation” that Britain is one of the few developed nations not to have ordered the drug, designed for those …

AstraZeneca boss calls for UK to provide new Covid-19 medicine to the vulnerable Read More »

Valneva approved to be UK’s sixth Covid vaccine

UK medicine regulator says it is first in world to approve Valneva product A Covid-19 vaccine developed by Valneva has been given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA). The UK’s independent medicines regulator is the first in the world to approve the Valneva product, MHRA said. Continue reading…

Oxford Covid jab gears up for final act: saving the rest of the world

After mishaps and misinformation, jab will build ‘global wall of immunity’, says director of Oxford Vaccine Group Exactly two years ago Prof Sir Andrew Pollard was starting to panic. “We were just waking up to the reality of Covid-19 and that we would need vaccines for our very survival,” the director of the Oxford Vaccine …

Oxford Covid jab gears up for final act: saving the rest of the world Read More »

Global powers inch closer to agreement to waive Covid vaccine patents

The move would allow for cheaper generic versions to be manufactured and distributed among developing nations faster Follow our Australia news live blog for the latest updates Get our free news app; get our morning email briefing Global powers have inched closer to an agreement to waive patents for Covid-19 vaccines, a move that would …

Global powers inch closer to agreement to waive Covid vaccine patents Read More »

Harry and Meghan add voices to fierce critique of west’s Covid vaccine policies

Pair join Gordon Brown and 126 others in attack on ‘self-defeating nationalism, pharmaceutical monopolies and inequality’ Prince Harry and Meghan, the actor Charlize Theron and the former British prime minister Gordon Brown are among 130 signatories to a letter lambasting wealthy countries’ approach to the Covid-19 pandemic, labelling it “immoral, entirely self-defeating and also an …

Harry and Meghan add voices to fierce critique of west’s Covid vaccine policies Read More »

The Covid treatment pill is here – and big pharma will ultimately decide who gets it | Othoman Mellouk

Experts are predicting demand for life-saving antiviral drugs will rapidly outpace supply. Like the vaccine, the poorest countries will be left until last Covid-19 has quietly become the gift that keeps on giving for big pharma. The past two years has seen it reap huge profits from Covid vaccines, while simultaneously opposing wider sharing of …

The Covid treatment pill is here – and big pharma will ultimately decide who gets it | Othoman Mellouk Read More »

AstraZeneca forecasts higher 2022 sales and lifts annual dividend

Drugmaker’s total revenues increased by 41% last year with help from $4bn Covid jab income AstraZeneca forecast higher 2022 sales and lifted its annual dividend for the first time in a decade after beating fourth-quarter profit expectations, but warned the boost from its Covid-19 products would decline. The Anglo-Swedish drugmaker made almost $4bn (£2.9bn) from …

AstraZeneca forecasts higher 2022 sales and lifts annual dividend Read More »

Yes, vaccines are lifesavers – but big pharma still needs to get its house in order | Laura Spinney

Despite the success of Covid jabs, there is huge – and understandable – mistrust of the pharmaceutical industry Last week, a commission set up by Stanford University and the Lancet found that the devastating opioid crisis in North America could happen again, and not just there. The unethical practices that Patrick Radden Keefe documented in …

Yes, vaccines are lifesavers – but big pharma still needs to get its house in order | Laura Spinney Read More »

Boost for GSK as it reports earnings at £1.4bn in Covid-related sales

Pharmaceutical company’s boss, Emma Walmsley promised a ‘step-change in growth’ after better than expected results GSK made £1.4bn from Covid-related medicines last year, beating earnings forecasts in its first financial results since rejecting Unilever’s £50bn buyout offer in December, as chief executive Emma Walmsley pledged “step-change in growth” in a landmark year. The company is …

Boost for GSK as it reports earnings at £1.4bn in Covid-related sales Read More »

The Guardian view on vaccine justice: the developing world won’t wait | Editorial

Only one in four African healthcare workers is protected. Regional production and patent waivers are needed No one asked for generosity – only justice. Self-interest as well as decency should have encouraged fairer distribution of vaccines: no one is safe until everyone is safe. Yet two years into the pandemic, with 8,400 people dying each …

The Guardian view on vaccine justice: the developing world won’t wait | Editorial Read More »

European Commission guilty of ‘maladministration’ over Pfizer texts

Regulator heavily critical of aides to Ursula von der Leyen in relation to Covid vaccine messages An investigation by an EU watchdog into text messages sent by European commission president Ursula von der Leyen to Pfizer’s chief executive has found the European Commission guilty of ‘maladministration’. Von der Leyen’s aides are heavily criticised in the …

European Commission guilty of ‘maladministration’ over Pfizer texts Read More »

Lifting England Covid rules while 3bn people unvaccinated reckless – experts

Scientists warn Boris Johnson that failure means new Covid variants will put thousands of lives at risk across UK Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has been accused of taking a reckless approach to public health by lifting all plan B Covid restrictions in England while failing to take enough …

Lifting England Covid rules while 3bn people unvaccinated reckless – experts Read More »

Novavax Covid vaccine: what is it and will it make a difference?

Australia’s government is hoping the protein-based vaccine – approved by the TGA – will sway the hesitant to get the jab Australia’s medicines regulator has approved the Novavax Covid-19 vaccine for use in adults. Nuvaxovid received provisional approval from the Therapeutic Goods Administration on Thursday, making it the fourth vaccine to be included in Australia’s …

Novavax Covid vaccine: what is it and will it make a difference? Read More »

More options for Covid treatments in January as FDA approves two antiviral pills

The approval comes as reports of shortages in monoclonal antibody treatment arise and cases spike People at greater risk of becoming seriously ill from Covid-19 will likely have more treatment options in January. That’s the forecast in the wake of the US Food and Drug Administration’s approval this week of the first two antiviral pills …

More options for Covid treatments in January as FDA approves two antiviral pills Read More »

UK, EU and US ‘get more Covid vaccines in six weeks than Africa has all year’

Analysis from People’s Vaccine Alliance highlights gulf as it calls for dose recipes to be shared Coronavirus – latest updates See all our coronavirus coverage The UK, European Union and the US have received more doses of Covid-19 vaccines in the past six weeks than African countries have all year, according to analysis from the …

UK, EU and US ‘get more Covid vaccines in six weeks than Africa has all year’ Read More »

Covid will not be our last global health crisis – we need a long-term plan | Jeff Sparrow

It’s nearly inevitable that we will face another pandemic. If we don’t plan to counter it, tomorrow will be like today, except much, much worse For decades, scientists warned that urban encroachment on pristine habitats would unleash dangerous new viruses. Covid-19 should not have been a surprise – and, since viruses always mutate, neither should …

Covid will not be our last global health crisis – we need a long-term plan | Jeff Sparrow Read More »

Moderna says booster produces strong antibody response to Omicron

Pharmaceuticals firm says third dose of its Covid vaccine increases antibodies against variant by 37-fold Coronavirus – latest updates See all our coronavirus coverage The pharmaceuticals company Moderna has said a booster dose of its Covid vaccine appeared to protect against the fast-spreading Omicron variant in laboratory testing and that the current version will continue …

Moderna says booster produces strong antibody response to Omicron Read More »

GSK/Sanofi Covid booster delayed by lack of uninfected people to test it on

Early trials show jab effective in people of all ages who have already received doses of any vaccine Coronavirus – latest updates See all our coronavirus coverage Efforts by the British and French drugmakers GSK and Sanofi Pasteur to produce a Covid-19 vaccine have suffered a further setback, with final clinical data on the jab …

GSK/Sanofi Covid booster delayed by lack of uninfected people to test it on Read More »

India’s Poonawalla family donate £50m for Oxford vaccine centre

Billionaire family own and run world’s largest vaccine producer, Serum Institute of India Coronavirus – latest updates See all our coronavirus coverage The family of the Indian billionaire and self-proclaimed “prince of vaccines” Adar Poonawalla are donating £50m to Oxford University for the construction of a new research centre that will house the team who …

India’s Poonawalla family donate £50m for Oxford vaccine centre Read More »

Pfizer says pill is effective in protecting against severe disease from Covid

Experimental antiviral pill Paxlovid is also effective against the Omicron variant, company announces A pill manufactured by the prominent Covid-19 vaccine provider Pfizer is highly effective in protecting against severe disease from coronavirus, the company said on Tuesday. The experimental antiviral pill Paxlovid is also effective against the Omicron variant that is spreading rapidly across …

Pfizer says pill is effective in protecting against severe disease from Covid Read More »

As Covid mutates, the vaccine makers are adapting too

Focus on the exciting potential of T-cell immunity is spurring the sector on to create a new generation of jabs The speed at which scientists worked to develop the first Covid jabs was unprecedented. Just nine months after the UK went into lockdown, 90-year-old Margaret Keenan officially became the first person in the world outside …

As Covid mutates, the vaccine makers are adapting too Read More »

‘Wall of secrecy’ in Pfizer contracts as company accused of profiteering

US company faces scrutiny over Covid profits after UK agrees to secrecy clause Coronavirus – latest updates See all our coronavirus coverage Ministers have agreed a secrecy clause in any dispute with the drugs manufacturer Pfizer over Britain’s Covid vaccine supply. Large portions of the government’s contracts with the company over the supply of 189m …

‘Wall of secrecy’ in Pfizer contracts as company accused of profiteering Read More »

Covid: scientists find possible trigger for AstraZeneca jab blood clots

Experts hope better understanding of rare side effect of vaccine could help ‘turn the tide’ on pandemic Coronavirus – latest updates See all our coronavirus coverage Scientists believe they may have found the trigger behind the extremely rare blood clot complications stemming from the Oxford/AstraZeneca’s Covid vaccine. According to a team of researchers from Cardiff …

Covid: scientists find possible trigger for AstraZeneca jab blood clots Read More »

UK ministers secure 114m more Covid vaccines for next two years

Extra Pfizer/BioNTech and Moderna jabs for 2022 and 2023 ordered to ‘future proof’ vaccine programme Coronavirus – latest updates See all our coronavirus coverage Ministers in the UK have secured new contracts to buy 114m more Covid-19 vaccines for the next two years. The deals, for 2022 and 2023, were accelerated after the emergence of …

UK ministers secure 114m more Covid vaccines for next two years Read More »

Prince Harry compares Covid vaccine inequity to HIV struggle

Duke of Sussex says on World Aids Day that vaccinating the world against Covid is ‘test of our moral character’ Coronavirus – latest updates See all our coronavirus coverage The Duke of Sussex has warned of “corporate greed and political failure” prolonging the Covid pandemic, comparing a “spectacular failure” of global vaccine equity to the …

Prince Harry compares Covid vaccine inequity to HIV struggle Read More »

Moderna boss predicts current vaccines may be less effective against Omicron covid

Stock markets dip as CEO says firms may struggle in targeting both new strain and existing Covid variants The chief executive of the US drugmaker Moderna has predicted that existing vaccines will be less effective against Omicron than they have been against the Delta version, sending global stock markets sharply lower. Stéphane Bancel said while …

Moderna boss predicts current vaccines may be less effective against Omicron covid Read More »

Developing nations may give up on the WTO for good if it won’t budge on vaccine patents | Nick Dearden

Covid has shown that the market cannot solve a global crisis. Now countries such as Britain must realise that too Late on Friday, with only days to go until its 12th summit was due to commence, the World Trade Organization (WTO) announced that its most important meeting of the year couldn’t proceed. With alarm spreading …

Developing nations may give up on the WTO for good if it won’t budge on vaccine patents | Nick Dearden Read More »

The Omicron variant reveals the true global danger of ‘vaccine apartheid’

Sharing vaccines with poorer countries is the right thing and the self-interested thing to do. The west needs to stop being so short-sighted Mandatory face masks are back in England. The fear factor has returned. After months of assuming the Covid-19 pandemic was all but over, the UK government has imposed new restrictions in an …

The Omicron variant reveals the true global danger of ‘vaccine apartheid’ Read More »

Boris Johnson ‘ignored’ my plan to tackle deadly Covid variants – senior official

Former head of vaccine taskforce says No 10 has not acted on his blueprint to prepare UK for new strains Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has been accused of ignoring a senior official’s plan to prepare Britain for the emergence of vaccine-resistant Covid variants, the Observer can reveal. With …

Boris Johnson ‘ignored’ my plan to tackle deadly Covid variants – senior official Read More »

AstraZeneca CEO links Europe’s Covid surge to rejection of its vaccine

Scientists sceptical about Pascal Soriot’s suggestion Oxford jab may give longer-lasting protection Coronavirus – latest updates See all our coronavirus coverage Scientists have reacted with scepticism to claims by AstraZeneca’s CEO that low uptake of the Oxford/AstraZeneca jab among elderly Europeans could explain the current surge in Covid-19 infections in mainland Europe. Pascal Soriot told …

AstraZeneca CEO links Europe’s Covid surge to rejection of its vaccine Read More »

Poorer nations still lack access to world’s key antibiotics

Only 54 of 166 assessed treatments have policies aiding use by low-income countries, says non-profit group The world’s biggest drugs makers have pressed on in the fight against superbugs despite the pandemic, but millions of people in poorer countries, where the risk of drug-resistant infections is highest, are still missing out on key antibiotics. A …

Poorer nations still lack access to world’s key antibiotics Read More »

The Guardian view on vaccine justice: what the world needs now | Editorial

While some in the west are triple-dosed, the vast majority of health workers in Africa remain unprotected. Gestures won’t close the gulf AstraZeneca’s halo has slipped. When it partnered with Oxford University, it promised to sell Covid vaccines at cost while the pandemic lasted; now it is signing its first for-profit deals, saying it believes …

The Guardian view on vaccine justice: what the world needs now | Editorial Read More »

UK firm to trial T-cell Covid vaccine that could give longer immunity

Exclusive: Oxfordshire-based Emergex gets go-ahead for trials in Switzerland for skin patch vaccine Coronavirus – latest updates See all our coronavirus coverage An Oxfordshire-based company will soon start clinical trials of a second-generation vaccine against Covid-19, an easy-to-administer skin patch that uses T-cells to kill infected cells and could offer longer-lasting immunity than current vaccines. …

UK firm to trial T-cell Covid vaccine that could give longer immunity Read More »

AstraZeneca’s new Covid treatment: what is it and how does it work?

Evusheld could offer higher protection against variants and help vulnerable people ward off virus Follow our Australia news live blog for the latest updates Five reasons NSW Covid case numbers have stayed low since reopening Vaccine rollout tracker; Cases and data tracker NSW Covid restrictions; Victoria restrictions Download the free Guardian app; get our morning …

AstraZeneca’s new Covid treatment: what is it and how does it work? Read More »

AstraZeneca to create dedicated Covid vaccines unit

Move intended to make it easier to continue producing coronavirus shot over the long term Coronavirus – latest updates See all our coronavirus coverage AstraZeneca is to create a new vaccines unit as the Anglo-Swedish drugmaker plans for the future of its coronavirus shot beyond the pandemic. The company said the reorganisation would bring together …

AstraZeneca to create dedicated Covid vaccines unit Read More »

Pfizer raises Covid-19 vaccine sales forecast to $36bn for 2021

US drugmaker expects to manufacture 3bn doses of vaccine with BioNTech this year Coronavirus – latest updates See all our coronavirus coverage The US drugmaker Pfizer has lifted its 2021 forecast for revenues from its Covid vaccine to $36bn (£26.3bn), after bumper sales in the third quarter. The Covid jab, called Comirnaty and developed with …

Pfizer raises Covid-19 vaccine sales forecast to $36bn for 2021 Read More »

Local Covid vaccines fill gap as UN Covax scheme misses target

India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind Developing countries are increasingly turning to homegrown Covid vaccinations as the UN-backed Covax programme falls behind. While western countries roll out booster jabs to their own populations, Covax, which was set up by UN agencies, governments and …

Local Covid vaccines fill gap as UN Covax scheme misses target Read More »

Pfizer asks US to allow Covid vaccines for children ages five to 11

Jabs could begin within weeks if US government approves request, with children getting a third of dose given to adults Pfizer asked the US government Thursday to allow use of its Covid-19 vaccine in children ages five to 11 – and if regulators agree, shots could begin within a matter of weeks. Many parents and …

Pfizer asks US to allow Covid vaccines for children ages five to 11 Read More »

Australia shores up Pfizer supply after days of uncertainty

John Frewen says company advised the government on Friday they would deliver the full 9m doses in October Australia will get its full supply of Pfizer next month, with the head of the country’s rollout saying the company had confirmed it would provide 9m doses in October as planned. After days of uncertainty over Pfizer …

Australia shores up Pfizer supply after days of uncertainty Read More »

Big pharma fuelling human rights crisis over Covid vaccine inequity – Amnesty

Six companies warned not to put profit before lives as report shows less than 1% of almost 6bn doses have gone to low-income countries Amnesty International has accused six pharmaceutical companies that have developed Covid-19 vaccines of fuelling a global human rights crisis, citing their refusal to sufficiently waive intellectual property rights, share vaccine technology …

Big pharma fuelling human rights crisis over Covid vaccine inequity – Amnesty Read More »

Ministers told to bar EU from UK trial data in vaccines row

England’s deputy medical chief asked for data to be withheld unless British vaccine guinea pigs allowed to travel abroad • Coronavirus – latest updates• See all our coronavirus coverage England’s deputy chief medical officer asked ministers to withhold all UK clinical trial data from the EU if European countries continued to deny entry to British …

Ministers told to bar EU from UK trial data in vaccines row Read More »

UK cancels Covid vaccine deal with French firm Valneva

Government serves notice to terminate contract over allegations of a ‘breach of obligations’ Coronavirus – latest updates See all our coronavirus coverage The UK government is to pull out of a deal with the French pharmaceutical company Valneva to purchase its Covid-19 vaccination, the company has said. The move will come as a blow to …

UK cancels Covid vaccine deal with French firm Valneva Read More »

A year that changed the world – and medical companies’ fortunes

While Covid sent many firms to the wall, others prospered by spotting opportunities, from test kits to mask coatings The pandemic has taken a heavy toll on business, gutting high streets as familiar names fell into receivership. But for some less well-known firms, the past 18 months have been transformational. Those that have thrived did …

A year that changed the world – and medical companies’ fortunes Read More »

BioNTech to seek approval for Covid jabs for younger children

Company behind Pfizer vaccine expected to file results of trial of five- to 11-year-olds with regulator soon Coronavirus – latest updates See all our coronavirus coverage The German company BioNTech, which developed the Pfizer vaccine, expects to seek approval from regulators for Covid jabs suited for younger children as early as mid-October, its founders have …

BioNTech to seek approval for Covid jabs for younger children Read More »

Pfizer accused of holding Brazil ‘to ransom’ over vaccine contract demands

Leaked supply document reveals clauses to protect US pharma company from legal action in the event of serious side-effects Coronavirus – latest updates See all our coronavirus coverage Pfizer has been accused of holding Brazil “to ransom” over demands to shield itself from possible vaccine side-effect lawsuits in its contract to supply the country with …

Pfizer accused of holding Brazil ‘to ransom’ over vaccine contract demands Read More »

Australian Novavax trial participants remain unrecognised by vaccine register

Covid vaccination status of hundreds in limbo because the US company’s jab is yet to be approved in Australia Vaccine rollout tracker; get our free news app; get our morning email briefing Australians who participated in clinical trials of the Novavax Covid vaccine are being told their vaccinations cannot currently be recognised on Australia’s immunisation …

Australian Novavax trial participants remain unrecognised by vaccine register Read More »

Japan’s Moderna Covid vaccine rollout hit by recall and contamination scares

Foreign materials including stainless steel identified in batches of Covid-19 vaccine though no safety or efficacy issues have been reported The Moderna coronavirus vaccine programme in Japan has been hit by a series of contamination incidents, prompting it to recall 1.63m doses found to contain metal fragments. Other potential contaminants have been identified in separate …

Japan’s Moderna Covid vaccine rollout hit by recall and contamination scares Read More »

Major shareholder’s Rolls-Royce grumble could rumble on

Vague demand for board refresh from Causeway likely a hangover from £2bn rights issue The last time Rolls-Royce had an US activist fund on its tail, the aero-engine manufacturer took the unusual step of inviting one of its representatives onto the board. ValueAct Capital was judged to have constructive ideas and useful industry expertise. The …

Major shareholder’s Rolls-Royce grumble could rumble on Read More »

UK approves rollout of ‘first of its kind’ Covid antibody treatment

Ronapreve can be used to treat symptoms of acute infection after successful clinical trials Coronavirus – latest updates See all our coronavirus coverage The medicines regulator has approved use of the first treatment in the UK using artificial antibodies to prevent and fight Covid-19. The health secretary, Sajid Javid, said approval of the first drug …

UK approves rollout of ‘first of its kind’ Covid antibody treatment Read More »

Drug firms poised to make billions of dollars from Covid booster jabs

Sales of BioNTech, Moderna and Pfizer drugs could rival $6bn-a-year market for flu vaccines, say analysts Coronavirus – latest updates See all our coronavirus coverage The drug companies Pfizer, BioNTech and Moderna are poised to make billions of dollars from Covid-19 booster jabs this autumn, with analysts estimating that sales could rival the $6bn-a-year market …

Drug firms poised to make billions of dollars from Covid booster jabs Read More »

Covid-19 vaccines: the contracts, prices and profits

Raised charges and Covax deals on order books of Pfizer, BioNTech, Moderna and AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Two US companies, Pfizer and Moderna, have raised the prices of their Covid-19 vaccines after data from clinical trials showed their mRNA formula was more effective than cheaper vaccines from Britain’s AstraZeneca …

Covid-19 vaccines: the contracts, prices and profits Read More »

UK orders extra Covid vaccines for autumn 2022 booster campaign

Pfizer reportedly asked to supply 35m more doses, with final go-ahead for this year’s programme still awaited Coronavirus – latest updates See all our coronavirus coverage Ministers have started ordering vaccines for a booster campaign in autumn 2022, with Pfizer reportedly being asked to supply the UK with a further 35m doses. The government has …

UK orders extra Covid vaccines for autumn 2022 booster campaign Read More »

AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021

Not-for-profit pledge sees British firm’s sales revenue fall significantly short of US rival Pfizer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s Covid-19 vaccine has brought in $1.2bn (£900m) in the first half of this year, with sales tripling in the second quarter from the first – but its earnings remained significantly below …

AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021 Read More »

Major delay in federal government’s Novavax deal, with 51m doses not expected until 2022

Initially touted as a ‘primary’ vaccine to help immunise Australia by the end of this year, Novavax will now form part of the booster strategy One of the federal government’s key vaccine deals has been hit with major delays, with 51 million doses of Novavax originally due to arrive in the second half of this …

Major delay in federal government’s Novavax deal, with 51m doses not expected until 2022 Read More »

US officials call for more data on vaccine boosters as Pfizer pushes for third shot

• Pharma company presses case with senior health officials • WHO urges priority for nations with low Covid vaccination rates Pfizer, the pharmaceutical company that created one of the first Covid-19 vaccines to be approved, has been making a hard sell for emergency approval of boosters – additional doses given to those already vaccinated, especially …

US officials call for more data on vaccine boosters as Pfizer pushes for third shot Read More »

Morrison government silent on contact with Pfizer global chief after Kevin Rudd intervenes in vaccine talks

Under fire for his government not reaching out to the pharmaceutical giant’s international head, health minister Greg Hunt also avoided naming the former Labor PM Scott Morrison and federal health minister Greg Hunt have not denied claims that they failed to press Australia’s case for more vaccine doses directly with Pfizer’s global chief, after revelations …

Morrison government silent on contact with Pfizer global chief after Kevin Rudd intervenes in vaccine talks Read More »

How should you respond to deep, sincere praise? There are no easy answers | Zoe Williams

On morning TV this week, two of the developers of the Oxford vaccine were faced with an outpouring of thanks. It was very much deserved – and very hard for them to reply I don’t watch much TV in the morning – I put it roughly on a par with smoking weed in the morning …

How should you respond to deep, sincere praise? There are no easy answers | Zoe Williams Read More »

Centre Court ovations, limbo-dancing grans – it’s all been humbling, say Oxford vaccine creators

Sarah Gilbert and Catherine Green tell of their pioneering vaccine work but warn the battle is far from over Coronavirus – latest updates See all our coronavirus coverage Sarah Gilbert’s experiences at Wimbledon last week clearly had a profound impact on the medical researcher – though it was not the standing ovation that the vaccine …

Centre Court ovations, limbo-dancing grans – it’s all been humbling, say Oxford vaccine creators Read More »

GSK firmly rejects Elliott Management’s demands over chief executive

Hedge fund had sought to force Emma Walmsley to reapply for her job ahead of drugmaker’s corporate split The drugmaker GlaxoSmithKline has issued a firm rejection of the main demands made by the activist investor Elliott Management, and insisted its chief executive, Emma Walmsley, would lead the new pharmaceuticals and vaccines company after a corporate …

GSK firmly rejects Elliott Management’s demands over chief executive Read More »

Million Pfizer jabs face being dumped after Israel-UK swap deal fails

Israel says technical issues have scuppered deal to give UK Covid vaccines expiring on 30 July Coronavirus – latest updates See all our coronavirus coverage More than a million Pfizer/BioNTech vaccine doses held in Israel that are due to expire at the end of July may be thrown away after attempts to broker a swap …

Million Pfizer jabs face being dumped after Israel-UK swap deal fails Read More »

The Oxford vaccine: the trials and tribulations of a world-saving jab

Amid bemusement from scientists at the deluge of often undeserved criticism, the Guardian pieces together the story behind the vaccine’s successes and failures Coronavirus – latest updates See all our coronavirus coverage In January 2020, when most of the world slept soundly in ignorance of the pandemic coming its way, a group of scientists at …

The Oxford vaccine: the trials and tribulations of a world-saving jab Read More »

Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy

Casual vaccine chat is today’s only form of small talk, so it’s not surprising it would take a lightheartedly tribal turn. Ultimately, of course, gratitude is at the heart of the conversation Last week, I had cause to go searching for images of men getting vaccinated (it’s not a fetish – it was for work) …

Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy Read More »

Covid jabs for billions of humans will earn their makers billions of dollars

We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive Coronavirus – latest updates See all our coronavirus coverage Drugmakers led by US firms Pfizer and Moderna stand to make tens of billions of dollars from their Covid-19 vaccines this …

Covid jabs for billions of humans will earn their makers billions of dollars Read More »

AstraZeneca vaccine price pledge omits some poor countries, contract shows

Exclusive: firm could charge more in places such as Zimbabwe and Sri Lanka once Covid pandemic is over Coronavirus – latest updates See all our coronavirus coverage AstraZeneca can charge a higher price for its Covid-19 vaccine in dozens of poor countries once the pharmaceutical company decides the pandemic has ended, according to a copy …

AstraZeneca vaccine price pledge omits some poor countries, contract shows Read More »

Vaccines were not part of AstraZeneca’s grand strategy, so what’s the plan now?

Having built a big operation during the pandemic it could stick or twist but either way investors will soon want a decision What’s AstraZeneca’s strategy in Covid treatments? In the short term, there is no confusion: the company will continue pumping out vaccine doses, will keep signing partnerships and will try to ignore churlishness in …

Vaccines were not part of AstraZeneca’s grand strategy, so what’s the plan now? Read More »

Drop Covid vaccine patent rules to save lives in world’s poorest countries, Britain and Germany told

G7 summit hears move would slash the cost of jabs and accelerate the rollout of programmes across the developing world Britain and Germany were last night under intense pressure to drop their resistance to proposals that would slash the cost of Covid-19 vaccines, following accusations that an agreement at the G7 summit to fund a …

Drop Covid vaccine patent rules to save lives in world’s poorest countries, Britain and Germany told Read More »

Covid vaccine programme for developing countries could cost $6.5bn

If pharmaceutical companies do not waive intellectual property rights the cost could reach $80bn Coronavirus – latest updates See all our coronavirus coverage The world’s developing countries could be vaccinated against Covid-19 at a cost of just $6.5bn (£4.6n) if pharmaceutical companies waive their intellectual property rights, under plans being outlined at the G7 summit …

Covid vaccine programme for developing countries could cost $6.5bn Read More »

Thailand starts Covid vaccine drive using jabs made by king’s firm

Country aims to vaccinate 70% of people this year but experts express doubts amid supply concerns Coronavirus – latest updates See all our coronavirus coverage Thailand has started its Covid vaccination campaign amid concerns over the supply of doses, which are mainly being produced locally by a royal-owned company that has no prior experience of …

Thailand starts Covid vaccine drive using jabs made by king’s firm Read More »

Fears of side-effects fuel reluctance to get Covid jabs, survey finds

Imperial College London survey in 15 countries also reveals worries that vaccines had not been tested enough Coronavirus – latest updates See all our coronavirus coverage Most people who are reluctant to be vaccinated against Covid are worried about side-effects and whether the vaccines have been adequately tested, a survey in 15 countries has shown. …

Fears of side-effects fuel reluctance to get Covid jabs, survey finds Read More »

MPs tell Johnson: you have a duty to help vaccinate the world

Exclusive: group urges prime minister to tackle ‘desperate shortage’ in developing nations Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has a “moral duty” to immediately start matching each vaccine administered at home with a donated dose to poorer countries across the world, a cross-party group of MPs and peers has said. …

MPs tell Johnson: you have a duty to help vaccinate the world Read More »

Taiwan accuses China of interfering with Covid vaccine deals

President says agreement with German firm BioNTech has been delayed after Beijing intervention Coronavirus – latest updates See all our coronavirus coverage Taiwan’s president has accused China of interfering in its vaccine acquisition programme, as the island continues to battle hundreds of daily new cases of Covid-19 with low supplies of vaccines. Taiwan has received …

Taiwan accuses China of interfering with Covid vaccine deals Read More »

Moderna jab stops Covid transmission in people aged 12 to 18, trial finds

Moderna becomes second manufacturer to announce successful trial results in younger people Coronavirus – latest updates See all our coronavirus coverage Mass vaccination of children against Covid-19 moved a step closer as Moderna became the second manufacturer to announce successful trial results, showing its vaccine can stop transmission in people aged 12 to 18. Pfizer/BioNTech’s …

Moderna jab stops Covid transmission in people aged 12 to 18, trial finds Read More »

AstraZeneca chief hits back at ‘armchair generals’ after criticism

Pascal Soriot defends firm and says its booster jab has performed well against new Covid variants in trials Coronavirus – latest updates See all our coronavirus coverage The chief executive of AstraZeneca has defended the company against “armchair generals” and said its vaccine has a future. Pascal Soriot disclosed the UK had priority access to …

AstraZeneca chief hits back at ‘armchair generals’ after criticism Read More »

Labour says UK must ‘get off the fence’ over global Covid vaccine access

Shadow trade secretary backs US call for patent waiver as party proposes plan to increase production in poorer countries Coronavirus – latest updates See all our coronavirus coverage The Labour party is urging Boris Johnson to lead a drive by rich countries to boost global Covid-19 vaccine production and is warning the threat from new …

Labour says UK must ‘get off the fence’ over global Covid vaccine access Read More »

Poorer countries face long delays in receiving Covid vaccines

Efforts in Africa and elsewhere hit by decision not to export AstraZeneca jab from India until end of year Coronavirus – latest updates See all our coronavirus coverage Vaccine programmes across Africa and much of the developing world will suffer big delays after the world’s biggest producer said it would not be exporting the Oxford/AstraZeneca …

Poorer countries face long delays in receiving Covid vaccines Read More »

GSK’s late entry to the vaccine race will help protect it from aggressive investors | Nils Pratley

Whatever Elliott Management’s intentions, the UK-based pharmaceutical firm will now be seen as a national asset GlaxoSmithKline’s progress on Covid vaccines has been slow, frustrating and surprising. More was expected sooner, because the company remains far bigger in the wider vaccine field than, say, AstraZeneca. But there are now tangible signs the pace is improving. …

GSK’s late entry to the vaccine race will help protect it from aggressive investors | Nils Pratley Read More »

Delay in giving second jabs of Pfizer vaccine improves immunity

Study finds antibodies against Sars-CoV-2 three-and-a-half times higher in people vaccinated again after 12 weeks rather than three Coronavirus – latest updates See all our coronavirus coverage The UK’s decision to delay second doses of coronavirus vaccines has received fresh support from research on the over-80s which found that giving the Pfizer/BioNTech booster after 12 …

Delay in giving second jabs of Pfizer vaccine improves immunity Read More »

Moderna says it has signed deal with Australia to supply 25m doses of Covid vaccine

Company says 10m could arrive by year’s end as it eyes local manufacturing opportunities Australians will have another vaccine option after the pharmaceutical company Moderna announced it has signed a deal with the federal government to provide 25m doses of its mRNA-based vaccine to the nation. The announcement was made overnight in a press release …

Moderna says it has signed deal with Australia to supply 25m doses of Covid vaccine Read More »

Pfizer warns Australia a Covid vaccine patent waiver could harm supply and safety

The pharmaceutical giant argues waiving intellectual property protections could see scarce inputs snapped up making it harder to produce vaccines Full Story podcast: Is Australia stopping the world’s poorest nations from accessing cheap vaccines? What is patent waiving and will it solve the global shortage? Pfizer has warned Australia against joining a growing push to …

Pfizer warns Australia a Covid vaccine patent waiver could harm supply and safety Read More »

AstraZeneca chief executive’s pay rise in doubt ahead of investor vote

Investors are lining up to oppose pay-and-perks plan for Pascal Soriot worth up to £17.8m for 2021 AstraZeneca could be forced to rip up plans to boost the pay of its chief executive, Pascal Soriot, as investors prepare to vote on proposals that could take his remuneration after nearly a decade at the helm of …

AstraZeneca chief executive’s pay rise in doubt ahead of investor vote Read More »

India records almost 4,200 Covid deaths in a day

County reports more than 400,000 new infections but experts suspect figures are gross underestimate Coronavirus – latest updates See all our coronavirus coverage Covid-19 deaths surged past 4,000 for the first time in India on Saturday in one of the world’s worst outbreaks. India reported a national record of 4,187 new deaths on Saturday. Continue …

India records almost 4,200 Covid deaths in a day Read More »

How US companies could use patients’ data from Covid vaccine drive

Privacy advocates warn retail pharmacies in particular are blurring the line between public health and commerce Data rights organizations have warned that patients lack a clear understanding of how information about their health, employment, contact or location details may be used if it is collected by private entities during the Covid-19 vaccine drive. Some advocates …

How US companies could use patients’ data from Covid vaccine drive Read More »

The Guardian view on waiving Covid vaccine patents: protect the world, not big pharma | Editorial

The US is now backing plans that could help billions more access vaccines. The UK should follow suit The rapid emergence of Covid vaccines has been a remarkable yet bittersweet success, pointing to both humanity’s scientific achievements and its social and economic failures. Experts created them at extraordinary speed; yet as the pandemic rages, many …

The Guardian view on waiving Covid vaccine patents: protect the world, not big pharma | Editorial Read More »

Pharmaceutical firms’ shares tumble after US plans patent waiver on Covid vaccines

Shares in Chinese and US companies fell sharply following announcement to boost production Coronavirus – latest updates See all our coronavirus coverage Shares in pharmaceutical companies fell sharply after the US government threw its weight behind global plans for a patent waiver on Covid-19 vaccines to boost their production and distribution around the world. Shortly …

Pharmaceutical firms’ shares tumble after US plans patent waiver on Covid vaccines Read More »

US support for Covid vaccine patent waivers puts pressure on EU and UK

Analysis: Joe Biden’s support for idea is vital but it won’t happen without backing of other rich nations Coronavirus – latest updates See all our coronavirus coverage It was a “seismic decision” by Joe Biden, the US president, say campaigners who have fought for the demolition of patent protection on vaccines and drugs for decades. …

US support for Covid vaccine patent waivers puts pressure on EU and UK Read More »

EU ‘ready to discuss’ waiver on Covid vaccine patents

Emmanuel Macron also supports US-backed proposal described as a gamechanger by WHO Coronavirus – latest updates See all our coronavirus coverage The head of the European commission, Ursula von der Leyen, has said the bloc is “ready to discuss” a US-backed proposal for a waiver on the patents for Covid-19 vaccines and the French president, …

EU ‘ready to discuss’ waiver on Covid vaccine patents Read More »

Pfizer forecasts $26bn from annual sales of Covid-19 vaccine

Vaccine will generate 73% more than forecast based on contracts signed until mid-April Coronavirus – latest updates See all our coronavirus coverage US drugmaker Pfizer expects to make $26bn (£19bn) in revenues from sales of its Covid-19 vaccine this year, with its soaraway product accounting for more than a third of the company’s annual income. …

Pfizer forecasts $26bn from annual sales of Covid-19 vaccine Read More »

Investors flock to life sciences as UK sector breaks funding record

Covid crisis spurs growing interest in drugmakers, diagnostics and medical equipment firms UK drugmakers, diagnostics, medical equipment and other life sciences companies have raised £10.6bn from private funding rounds and stock market flotations in the first three months of the year, more than half of last year’s record total, according to a report. Last year, …

Investors flock to life sciences as UK sector breaks funding record Read More »

AstraZeneca revenues up as it delivers jab to 120 countries via Covax

Quarterly results from Anglo-Swedish producer of Covid vaccine show better-than-expected 15% rise Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has generated $275m (£197m) in revenues from its Covid vaccine in the first three months of the year and shipped 48m doses to 120 countries through the global vaccine-sharing initiative Covax. Most of …

AstraZeneca revenues up as it delivers jab to 120 countries via Covax Read More »

India wants access to cheap copies of Covid vaccines. So why is Australia holding out?

More than 100 countries are pushing for a temporary waiver of IP rules to boost vaccine access for developing nations. Why hasn’t it been approved? As India grapples with a devastating Covid wave that has overwhelmed its hospitals, offers of aid, including from Australia, have flooded in from around the world. The help on offer …

India wants access to cheap copies of Covid vaccines. So why is Australia holding out? Read More »

UK orders 60m more doses of Pfizer Covid vaccine for booster jabs

Health secretary says greater supplies of vaccine will help safeguard progress in tackling coronavirus Coronavirus – latest updates See all our coronavirus coverage The UK has ordered a further 60m doses of the Pfizer/BioNTech Covid vaccine in an effort to ensure that booster jabs can be given from this autumn, the government has announced. The …

UK orders 60m more doses of Pfizer Covid vaccine for booster jabs Read More »

EU starts legal action against AstraZeneca over vaccine shortfalls

Firm says it will ‘strongly defend itself’ against claim it breached agreement to supply Covid jab Coronavirus – latest updates See all our coronavirus coverage AstraZeneca said it would “strongly defend itself in court” and highlighted its supply of 50m Covid vaccine doses to European countries as Brussels launched legal action against the pharmaceutical company …

EU starts legal action against AstraZeneca over vaccine shortfalls Read More »

What Covid vaccines does the UK have and which are in the works?

As Valneva recruits volunteers for final stage trials of its vaccine, here is the current state of play in Britain Coronavirus – latest updates See all our coronavirus coverage Vaccines to protect against the coronavirus were designed, tested and manufactured in record time, and several have been approved for use in the UK vaccination programme, …

What Covid vaccines does the UK have and which are in the works? Read More »

In the fight against Covid, have we been inoculated against compassion? | Letters

Dr Mohga Kamal-Yanni says world leaders must stop putting big pharma’s profits before people’s lives. Sue Hoar wonders why more is not being done to help Covid patients in India The shortfall in Covid vaccine doses going to the Covax vaccine-sharing scheme is deeply worrying, and highlights a massive flaw in the plans to provide …

In the fight against Covid, have we been inoculated against compassion? | Letters Read More »

GlaxoSmithKline faces dose of strong medicine from US investor

This week’s lacklustre results will strengthen boss Emma Walmsley’s case for reform – but also inspire her critics When the American hedge fund Elliott Management took a sizeable stake in GlaxoSmithKline this month, the drugmaker’s shares jumped 5% on speculation of a possible shake-up at the company. GSK’s chief executive, Emma Walmsley, will face questions …

GlaxoSmithKline faces dose of strong medicine from US investor Read More »

The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi

Pharmaceutical companies insist secrecy is the only way. But what if they were obliged to share recipes and supply chains? Biolyse is a small pharmaceutical manufacturer in Canada with a simple proposition: provide a recipe for a coronavirus vaccine, and it will produce 20m doses for nations in the global south. It has approached AstraZeneca …

The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi Read More »

EU asks states to back legal action against AstraZeneca

Commission move causes concern about bringing case against key supplier of Covid vaccines Coronavirus – latest updates See all our coronavirus coverage EU capitals have been asked by the European commission to back legal action against AstraZeneca by the end of the week over an alleged breach of its contractual obligations to supply member states …

EU asks states to back legal action against AstraZeneca Read More »

Revealed: big shortfall in Covax Covid vaccine-sharing scheme

Only a fifth of doses expected by May delivered as export bans, hoarding and supply shortages bite Coronavirus – latest updates See all our coronavirus coverage The global vaccine-sharing initiative Covax has so far delivered about one in five of the Oxford/AstraZeneca doses it estimated would arrive in countries by May, according to a Guardian …

Revealed: big shortfall in Covax Covid vaccine-sharing scheme Read More »

The Covid crisis: some people think it’s all over … it isn’t

A new reality check is coming unless the west replicates its ‘whatever-it-takes approach’ to help poorer countries cope Denial. Panic. False dawn. Relief mingled with a decent dollop of euphoria. Britain’s response to Covid-19 has moved through distinct phases, and there are at least two more to come. Despite the success of the vaccine programme, …

The Covid crisis: some people think it’s all over … it isn’t Read More »

Covid booster shot warning ‘underlines urgent need for Australia to make mRNA vaccines’

Pfizer boss flags likelihood that extra jabs will be required – raising prospect of increased global demand Covid booster shot could be needed after nine to 12 months, White House says Experts say suggestions that a third dose of Pfizer may be needed within 12 months again show why Australia “urgently” needs to develop an …

Covid booster shot warning ‘underlines urgent need for Australia to make mRNA vaccines’ Read More »

Oxford/AstraZeneca Covid vaccine research ‘was 97% publicly funded’

Analysis rebuts claim by Boris Johnson that jab was developed ‘because of greed’ Coronavirus – latest updates See all our coronavirus coverage At least 97% of the funding for the development of the Oxford/AstraZeneca Covid-19 vaccine has been identified as coming from taxpayers or charitable trusts, according to the first attempt to reconstruct who paid …

Oxford/AstraZeneca Covid vaccine research ‘was 97% publicly funded’ Read More »

Will Covid vaccines protect us against new variants? | Julian Tang

New strains such as the South African variant that’s emerged in south London will require constant vigilance as lockdown eases All viruses mutate. They do this to adapt and survive better in their specific host. The virus that causes Covid-19 is no different: it has moved from the animal realm, where it most likely originated …

Will Covid vaccines protect us against new variants? | Julian Tang Read More »

UK strategy of backing several Covid vaccines seems to be paying off

Analysis: buying new and existing technologies ensured alternatives if a vaccine failed or had supply issues Coronavirus – latest updates See all our coronavirus coverage The government has said the decision by Johnson & Johnson to delay the supply of its Covid vaccine to Europe, while the US investigates reports of six cases of unusual …

UK strategy of backing several Covid vaccines seems to be paying off Read More »

EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay

Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage The European commission is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it has decided to delay the deployment of its coronavirus vaccine across …

EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay Read More »

African health workers left without Covid jabs as paltry supplies dwindle

Fear of third wave and new variants as sub-Saharan vaccine distribution is dogged by supply disruption Coronavirus – latest updates See all our coronavirus coverage Millions of healthcare workers in sub-Saharan Africa continue to risk their lives to fight Covid-19 as authorities across the continent struggle to obtain and distribute vaccines to frontline medical staff. …

African health workers left without Covid jabs as paltry supplies dwindle Read More »

Global Covid vaccine rollout threatened by shortage of vital components

Pharmaceutical firms warn of delays to items such as the large bags in which vaccine cells are grown Coronavirus – latest updates See all our coronavirus coverage Vaccine-makers around the world face shortages of vital components including large plastic growbags, according to the head of the firm that is manufacturing a quarter of the UK’s …

Global Covid vaccine rollout threatened by shortage of vital components Read More »

EU agency examines reports of blood clots with J&J Covid vaccine

EMA says four serious cases reported, one fatal, and also expands inquiry into AstraZeneca vaccine Coronavirus – latest updates See all our coronavirus coverage The EU’s drug regulator is reviewing reports of rare blood clots in four people who received Johnson & Johnson’s Covid-19 vaccine and has expanded its inquiry into AstraZeneca’s shot to include …

EU agency examines reports of blood clots with J&J Covid vaccine Read More »

Clarity and openness are key to vaccine confidence | Letters

Readers respond to the latest recommendations about the AstraZeneca Covid vaccine Your editorial calling for clarity on the AstraZeneca vaccine’s side-effects risks both being unclear and undermining confidence (The Guardian view on the AstraZeneca vaccine: confidence from clarity, 7 April). You imply that the rate of potentially serious cerebral venous sinus thrombosis is 0.0001%. The …

Clarity and openness are key to vaccine confidence | Letters Read More »

What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?

Experts say the development of blood clots after getting the jab is still an ‘exceedingly rare’ side effect. So what triggered the government’s change in position? Australia’s vaccine rollout is facing a major shake-up after the federal government heeded the advice of its independent health expert advisory body to avoid giving the AstraZeneca vaccine to …

What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk? Read More »

Coronavirus: UK expert urges people in 20s to keep getting vaccine

Prof David Spiegelhalter says advantages of vaccinating young people far outweigh risks Coronavirus – latest updates See all our coronavirus coverage People in their 20s should continue to get vaccinated against Covid despite the very rare cases of blood clotting linked to the Oxford/AstraZeneca vaccine because of the wider benefit to their families, friends and …

Coronavirus: UK expert urges people in 20s to keep getting vaccine Read More »

UK ministers silent on AstraZeneca vaccine shipment to Australia

Downing Street will not confirm or deny report that more than 700,000 Covid jabs were sent after EU blocked export Coronavirus – latest updates See all our coronavirus coverage British ministers and officials did not deny that more than 700,000 shots of the AstraZeneca vaccine were secretly dispatched from the UK to Australia a few …

UK ministers silent on AstraZeneca vaccine shipment to Australia Read More »

A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay

Vaccitech, the Oxford-based firm behind the AstraZeneca vaccine, is a high-profile float that slipped away A glowing, Deliveroo-style tribute from Rishi Sunak will not be required for this flotation. Vaccitech, the Oxford-based firm that owns some of the key biotechnology behind the AstraZeneca Covid vaccine, is off to New York for a public listing. One …

A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay Read More »

Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam

England’s deputy chief medical officer says delay would be precaution against rare side-effect of blood clots Coronavirus – latest UK updates See all our coronavirus coverage People under 30 have been told there may be a “small delay” to when they will receive a coronavirus vaccine, given adults in that age group are now being …

Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam Read More »

AstraZeneca jab: UK government says concerns being investigated thoroughly

People urged to keep getting Covid vaccine, with EMA and MHRA expected to give updates on investigation into rare blood clots Coronavirus – latest updates See all our coronavirus coverage Government advisers say concerns over the Oxford/AstraZeneca jab are being taken “very seriously” and “very thoroughly” investigated, before an imminent announcement by the vaccines regulator. …

AstraZeneca jab: UK government says concerns being investigated thoroughly Read More »

AstraZeneca Covid vaccine: weighing up the risks and rewards

Despite scientific advice to continue getting the jab, answers about fatal blood clots are urgently needed Coronavirus – latest updates See all our coronavirus coverage Vaccines have side-effects, as do all medicines. Most often, jabs cause sore arms, a headache or a bit of nausea – none of which would be very significant when weighed …

AstraZeneca Covid vaccine: weighing up the risks and rewards Read More »

Medicines watchdog says no decision made AstraZeneca jab for under-30s

Medicines Healthcare products Regulatory Authority was considering restricting vaccine amid concerns over rare blood clots Coronavirus – latest updates See all our coronavirus coverage The UK’s medicines regulatory body has said that no decision has been made on any regulatory action relating to the Oxford/AstraZeneca vaccine following reports it is considering restricting use of the …

Medicines watchdog says no decision made AstraZeneca jab for under-30s Read More »

Blood clot cases ‘could dent faith of young women in AstraZeneca’

Experts urge public to go for inoculations as benefits far outweigh potential complications Coronavirus – latest updates See all our coronavirus coverage Health officials are becoming increasingly worried that younger people will reject Covid jabs as concerns about the AstraZeneca vaccine continue to grow. A total of 30 cases of rare blood clots have been …

Blood clot cases ‘could dent faith of young women in AstraZeneca’ Read More »

Two new vaccines on the way – with more to follow this year

Half of UK adults have had a first jab, and future supplies of millions of doses look assured Coronavirus – latest updates See all our coronavirus coverage Two very different jabs have been responsible for inoculating Britain’s strikingly high number of vaccine recipients – with more than half of the country’s adult population having now …

Two new vaccines on the way – with more to follow this year Read More »

Pfizer vaccine has 91% efficacy for up to six months, trial shows

Findings based on two doses three weeks apart are first to show shot remains effective for many months Coronavirus – latest updates See all our coronavirus coverage The coronavirus vaccine developed by Pfizer and its German partner BioNTech protects against symptomatic Covid for up to six months, an updated analysis of clinical trial data has …

Pfizer vaccine has 91% efficacy for up to six months, trial shows Read More »

Pfizer finds Covid vaccine safe and effective for children 12 to 15

Drug firm in partnership with BioNTech to seek US approval after trials found vaccine ‘well-tolerated’ in school-age children Pfizer plans to seek emergency approval for its Covid vaccine in younger people after a US trial found the jab prevented the disease and was “well-tolerated” in 12- to 15-year-olds. Related: Germany restricts use of AstraZeneca jab …

Pfizer finds Covid vaccine safe and effective for children 12 to 15 Read More »

UK to make up to 60m doses of Novavax Covid vaccine under GSK deal

Deal is intended to boost domestic supply amid fears potential export bans could hit vaccine shipments Coronavirus – latest updates See all our coronavirus coverage The UK will produce up to 60m doses of a Covid-19 vaccine under a new deal struck to boost domestic supply, amid fears over potential export bans hitting shipments of …

UK to make up to 60m doses of Novavax Covid vaccine under GSK deal Read More »

Safe, stable, sold at cost: AstraZeneca’s vaccine deserves celebration, not scorn

The company has struggled, like its rivals, to keep up with demand. But it has achieved great things at low prices AstraZeneca is one of the shining stars of the pandemic. Not only did it produce a vaccine where other big players failed, the UK-Swedish company has pledged to sell it at cost until it …

Safe, stable, sold at cost: AstraZeneca’s vaccine deserves celebration, not scorn Read More »

‘Vaccine prince’: the Indian billionaire set to make Covid jabs for the UK

Serum Institute boss Adar Poonawalla has rented a Mayfair mansion for £50,000 a week Coronavirus – latest updates See all our coronavirus coverage The AstraZeneca vaccine has made Prof Sarah Gilbert – who led the Oxford team that created it – one of the UK’s most famous modern scientists and turned the Anglo-Swedish pharmaceutical company …

‘Vaccine prince’: the Indian billionaire set to make Covid jabs for the UK Read More »

How the AstraZeneca vaccine became a political football – and a PR disaster

Newly accused of data manipulation by the US, AstraZeneca has faced unprecedented scrutiny over the past six months Coronavirus – latest updates See all our coronavirus coverage It was billed as the vaccine to deliver the world from Covid. But over the last six months, AstraZeneca – whose jab was designed to save thousands of …

How the AstraZeneca vaccine became a political football – and a PR disaster Read More »

AstraZeneca dismisses claim 29m vaccine doses in Italy were bound for UK

Batches were found when Italian police searched factory at request of European commission Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has dismissed as “inaccurate” a report in the Italian press that 29m doses of its Covid-19 vaccine found in factory near Rome were destined for the UK. La Stampa reported on Wednesday …

AstraZeneca dismisses claim 29m vaccine doses in Italy were bound for UK Read More »

AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data

Worldwide focus on Covid-19 means a ‘minor issue’ is getting media attention, experts say Australia’s Covid vaccine rollout would be ‘dire’ without local AstraZeneca production, health chief says Australia’s drug regulator, the Therapeutic Goods Administration, has dismissed questions raised about “outdated information” in AstraZeneca vaccine data by the US Data and Safety Monitoring Board. On …

AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data Read More »

EU to widen criteria for possible Covid vaccine export bans

Bloc expected to assess countries’ Covid vaccination coverage and record in facilitating exports to EU Coronavirus – latest updates See all our coronavirus coverage The EU is expected to take into account the level of vaccination coverage in a country and its record in facilitating exports to the bloc when deciding on whether to prohibit …

EU to widen criteria for possible Covid vaccine export bans Read More »

US agency questions AstraZeneca’s Covid vaccine trial data

Drug firm may have provided incomplete view of efficacy data from US trial, says safety monitor Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine against Covid has been dealt another blow within hours of AstraZeneca posting excellent results from its long-awaited big trial in the US. Questions have been raised in …

US agency questions AstraZeneca’s Covid vaccine trial data Read More »

The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial

Vaccinating the world is the only way out of Covid, but a mixture of nationalism and protectionism is blocking the exit Covid-19 has proved to be the greatest humanitarian and economic disaster of the century. A reported 2.7 million people have already died from the pathogen. Its recession is estimated to be twice as deep …

The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial Read More »

Boris Johnson: vaccine cooperation vital to help combat third Covid wave

PM stresses need to work with EU and says surge in infections is likely to ‘wash up on our shores’ Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has urged international cooperation over vaccines, saying a third wave of coronavirus elsewhere in Europe would inevitably affect the UK. The prime minister’s remarks …

Boris Johnson: vaccine cooperation vital to help combat third Covid wave Read More »

Vaccine wars: the week that rocked the UK’s Covid jab rollout

After a week of bans, U-turns and warnings of supply shortfalls, public confidence in vaccination has been dented. Can Britain get back on the fast track out of lockdown? Coronavirus – latest updates See all our coronavirus coverage For Stacey Harris, the hardest part of organising vaccinations over the last couple of months has been …

Vaccine wars: the week that rocked the UK’s Covid jab rollout Read More »

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator …

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously Read More »

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator …

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously Read More »

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe

Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live in the European Union – in my case, in Spain. …

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe Read More »

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe

Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live in the European Union – in my case, in Spain. …

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe Read More »

How are Covid vaccines produced and why have there been delays?

The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of the pandemic was almost within reach. Few, however, had anticipated …

How are Covid vaccines produced and why have there been delays? Read More »

How are Covid vaccines produced and why have there been delays?

The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of the pandemic was almost within reach. Few, however, had anticipated …

How are Covid vaccines produced and why have there been delays? Read More »

European countries to resume AstraZeneca jabs after safety backing

EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its …

European countries to resume AstraZeneca jabs after safety backing Read More »

European countries to resume AstraZeneca jabs after safety backing

EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its …

European countries to resume AstraZeneca jabs after safety backing Read More »

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video

The Oxford/AstraZeneca coronavirus vaccine is ‘safe and effective’ and its benefits outweigh the risks, Europe’s medicines regulator has said. The director of the European Medicines Agency, Emer Cooke, said the agency’s safety committee had reached ‘a clear scientific conclusion’ and had not found that the vaccine was associated with an increase in the overall risk of …

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video Read More »

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video

The Oxford/AstraZeneca coronavirus vaccine is ‘safe and effective’ and its benefits outweigh the risks, Europe’s medicines regulator has said. The director of the European Medicines Agency, Emer Cooke, said the agency’s safety committee had reached ‘a clear scientific conclusion’ and had not found that the vaccine was associated with an increase in the overall risk of …

AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video Read More »

EU to send formal letter to AstraZeneca in Covid vaccine dispute

Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine supplies, a spokesperson has said, as it emerged that capitals …

EU to send formal letter to AstraZeneca in Covid vaccine dispute Read More »

EU to send formal letter to AstraZeneca in Covid vaccine dispute

Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine supplies, a spokesperson has said, as it emerged that capitals …

EU to send formal letter to AstraZeneca in Covid vaccine dispute Read More »

Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA

European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend use Coronavirus – latest updates See all our coronavirus coverage Europe’s medicines regulator has moved to stifle spiralling concern about the Oxford/AstraZeneca vaccine, saying the shot’s benefits outweigh the risks after four major EU countries announced they were suspending its …

Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA Read More »

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns

Deployment of Oxford vaccine temporarily deferred after latest reports from Norway Coronavirus – latest updates See all our coronavirus coverage Ireland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received it, this time from Norway. The deputy chief medical officer, …

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns Read More »

Israeli real-world data on Pfizer vaccine shows high Covid protection

Jab has 97% efficacy against disease and death and 94% against infection without symptoms The Pfizer/BioNTech vaccine appears to give high protection against asymptomatic Covid-19, according to data from Israel – a finding that will boost hopes that mass vaccination can stop the spread of the virus. The top line of the real-world results, issued …

Israeli real-world data on Pfizer vaccine shows high Covid protection Read More »

Denmark pauses use of AstraZeneca vaccine to investigate blood clot reports

Health agency suspends use of Covid jab but says no conclusive link has been established Coronavirus – latest updates See all our coronavirus coverage Denmark’s national health agency has said it is temporarily suspending inoculations with the AstraZeneca vaccine after blood clots formed in several people who had the jab, one of whom has reportedly …

Denmark pauses use of AstraZeneca vaccine to investigate blood clot reports Read More »

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot

The scientific community are rising to the challenge, undertaking an unprecedented global health programme Pascal Soriot is the chief executive officer of AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Covid-19 is a virus that knows no boundaries and has inflicted terrible suffering across the world. Now more than ever, we must remember …

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot Read More »

BioNTech co-founder says gender equality made vaccine possible

Özlem Türeci credits firm’s more than 50% female workforce for speed at which first viable jab created The co-founder and chief medical officer of BioNTech has credited its speed at producing a viable vaccine to the fact its workforce is more than 50% female. Speaking on International Women’s Day, Özlem Türeci also said the fact …

BioNTech co-founder says gender equality made vaccine possible Read More »

From Pfizer to Moderna: who’s making billions from Covid vaccines?

The companies in line for the biggest gains – and the shareholders who have already made fortunes Coronavirus – latest updates See all our coronavirus coverage The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for …

From Pfizer to Moderna: who’s making billions from Covid vaccines? Read More »

Australia requests review of Italy’s block of vaccine export

Italian government said the 250,000 doses of AstraZeneca vaccine must be kept in EU Coronavirus – latest updates See all our coronavirus coverage Australia has asked for a review of Italy’s decision to block the export of 250,000 doses of the AstraZeneca vaccine to its shores. In the first such intervention under the EU’s controversial …

Australia requests review of Italy’s block of vaccine export Read More »

Italy blocks export of 250,000 AstraZeneca vaccine doses to Australia

Row continues between EU and drug firm after shortfall in vaccine deliveries to bloc Coronavirus – latest updates See all our coronavirus coverage Italy has blocked the export of 250,000 doses of the Oxford/AstraZeneca vaccine to Australia in an escalation of a row with the Anglo-Swedish company. In the first such intervention under the EU’s …

Italy blocks export of 250,000 AstraZeneca vaccine doses to Australia Read More »

Pfizer vaccine may be less effective in people with obesity, says study

Healthcare workers with obesity found to produce only about half the antibodies healthy people do Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine may be less effective in people with obesity, data suggests. Italian researchers have discovered that healthcare workers with obesity produced only about half the amount of antibodies in …

Pfizer vaccine may be less effective in people with obesity, says study Read More »

Johnson & Johnson one-shot Covid vaccine gets nod from FDA advisory panel

Vaccine, along with those from Pfizer and Moderna, should provide US with more than enough supply to vaccinate every person The battle against Covid-19 took a major step forward on Friday as the US moved closer to distributing its first one-shot Covid-19 vaccine, after an independent expert advisory panel recommended drug regulators authorize the Johnson …

Johnson & Johnson one-shot Covid vaccine gets nod from FDA advisory panel Read More »

Blair says collaboration on Covid could have cut three months off crisis

Former prime minister tells the Guardian the world must be better prepared for the next pandemic World leaders could have cut the length of the Covid outbreak by three months if they had collaborated on vaccines, testing and drugs, Tony Blair has claimed as he launched a report on preparing for the next deadly pandemic. …

Blair says collaboration on Covid could have cut three months off crisis Read More »

Australia considers approving Pfizer Covid vaccine for standard cold storage

Therapeutic Goods Administration may follow US in allowing vaccines to be stored at warmer temperatures Pfizer’s Covid-19 vaccine could soon be delivered at temperatures 50 degrees warmer than currently required if Australia follows the US’s lead to ease the rollout. The potential change in storage temperature requirements is being considered as the federal health department …

Australia considers approving Pfizer Covid vaccine for standard cold storage Read More »

Moderna forecasts $18bn in sales of Covid vaccine this year

Better than expected revenues will push US firm founded in 2010 into profit for first time Coronavirus – latest updates See all our coronavirus coverage Moderna expects to rake in $18.4bn (£13bn) of sales from its coronavirus vaccine this year, marking a huge turnaround in the fortunes of the US biotech firm. The expected revenue …

Moderna forecasts $18bn in sales of Covid vaccine this year Read More »

Vaccine clinical trials for Covid variants to start in summer, MPs told

Updated versions of vaccine are being developed in case variants evade immunity provided by current shots Coronavirus – latest updates See all our coronavirus coverage Clinical trials of vaccines against new variants of coronavirus will start in the summer to ensure updated boosters are available for the autumn if needed, Oxford’s lead vaccine researcher has …

Vaccine clinical trials for Covid variants to start in summer, MPs told Read More »

AstraZeneca expected to miss EU Covid vaccine supply target by half in second-quarter – report

Expected shortfall of 90m doses could hit the EU’s ability to meet its target of vaccinating 70% of adults by summer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has told the European Union it expects to deliver less than half the Covid-19 vaccines it was contracted to supply in the second quarter, …

AstraZeneca expected to miss EU Covid vaccine supply target by half in second-quarter – report Read More »

Number of UK Covid vaccinations falls by a third as vaccine supply dips

Factors at play include high uptake plus stockpiling for second doses, but Matt Hancock promises ‘bumper weeks in March’ Coronavirus – latest updates See all our coronavirus coverage The number of Covid vaccines administered in the UK has fallen by over a third in the last week as ministers warned of a short-term dip in …

Number of UK Covid vaccinations falls by a third as vaccine supply dips Read More »

South Africa leads backlash against big pharma over access to Covid vaccines

Pressure mounts for patent waivers to allow poorer countries to develop their own manufacturing capacity to boost availability The domination of global medicine by major pharmaceutical companies needs to be confronted to provide fairer access to vaccines, a leading South African official has said. The scramble over Covid vaccines should alert rich countries to the …

South Africa leads backlash against big pharma over access to Covid vaccines Read More »

‘It shows what we’re capable of’: the NHS’s vaccine triumph

A huge effort has helped the UK provide 14m first doses of Covid vaccines in about two months Coronavirus – latest updates See all our coronavirus coverage In St Albans, GPs took over a former nightclub to provide Covid vaccinations every 20 seconds; in Carnforth, Lancashire, delivering jabs was helped by volunteers from the local …

‘It shows what we’re capable of’: the NHS’s vaccine triumph Read More »

AstraZeneca says vaccine against new Covid variants may take six months

Anglo-Swedish pharmaceutical firm’s profits rise to $7.4bn as main business ‘remains strong’ Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has said it could take between six and nine months to produce Covid-19 vaccines that are effective against new variants of the coronavirus. The company’s vaccine, developed jointly with scientists at the University …

AstraZeneca says vaccine against new Covid variants may take six months Read More »

A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence

From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulators Coronavirus – latest updates See all our coronavirus coverage The Oxford University/AstraZeneca vaccine against Covid has barely been out of the news from the moment the race to protect the world’s population from …

A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence Read More »

Oxford Covid vaccine 10% effective against South African variant, study suggests

Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have suggested. Scientists who conducted a small-scale trial of the vaccine’s …

Oxford Covid vaccine 10% effective against South African variant, study suggests Read More »

UK orders 50m doses of Covid vaccines in fight against variants

Government to work with German firm CureVac on tackling potential mutations Coronavirus – latest updates See all our coronavirus coverage The UK government has signed a deal for at least 50m doses of vaccines that could combat new variants of coronavirus, and is to work with the German manufacturer to help develop them. The Department …

UK orders 50m doses of Covid vaccines in fight against variants Read More »

One Pfizer/BioNTech jab gives ‘90% immunity’ from Covid after 21 days

New analysis runs counter to earlier study which suggested one dose may not give adequate protection Coronavirus – latest updates See all our coronavirus coverage One dose of the Pfizer/BioNTech vaccine gives people about 90% protection from Covid by 21 days, according to an analysis of Israel’s mass vaccination programme. The data analysis, carried out …

One Pfizer/BioNTech jab gives ‘90% immunity’ from Covid after 21 days Read More »

GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine

Companies hope to have next generation of vaccines against emerging variants by next year GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic. The two companies said they they plan to work jointly to develop a vaccine that can …

GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine Read More »

Single dose of AstraZeneca vaccine could cut transmission by 67%

One jab could also offer protection of up to 76% for up to 12 weeks, a new study shows Coronavirus – latest updates See all our coronavirus coverage A single dose of the Oxford/AstraZeneca vaccine may reduce transmission by 67% and give protection of 76% for up to 12 weeks, a study shows. Vaccine efficacy …

Single dose of AstraZeneca vaccine could cut transmission by 67% Read More »

France and Germany threaten AstraZeneca over vaccine shortage

Warning of ‘legal commitment’ and concern that doses might have been diverted from the EU to the UK Coronavirus – latest updates See all our coronavirus coverage France and Germany have threatened legal action against the Anglo-Swedish pharmaceutical company AstraZeneca in the row over a shortage of coronavirus vaccine in the EU. Talks between the …

France and Germany threaten AstraZeneca over vaccine shortage Read More »

How EU’s floundering vaccine effort hit a fresh crisis with exports row

A new rule on exports from Europe suddenly blew up into a threat to the withdrawal agreement – and a hasty backtrack Coronavirus – latest updates See all our coronavirus coverage It started with a tweet by a blogger at 4.36pm on Friday. It ended with the prime ministers of the UK and Ireland warning …

How EU’s floundering vaccine effort hit a fresh crisis with exports row Read More »

EU to publish revised rules after Covid vaccine border fiasco

Commission plans to rush through regulations that ‘ensure Northern Ireland protocol remains unaffected’ Coronavirus – latest updates See all our coronavirus coverage Explainer: what is article 16 of the Northern Ireland protocol? Brussels will publish a revised regulation to potentially block vaccine exports out of the EU on Saturday, after an international outcry over its …

EU to publish revised rules after Covid vaccine border fiasco Read More »

UK vaccine strategy ‘paying off’ as latest trials boost stockpiles

Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs Coronavirus – latest updates See all our coronavirus coverage Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive trial results – potentially growing the UK stockpile by 90m …

UK vaccine strategy ‘paying off’ as latest trials boost stockpiles Read More »

What can moral philosophy tell us about the Covid ‘vaccine nationalism’ row? | Alexis Papazoglou

The shortfall in supply has put the EU and the UK at loggerheads, but ethical principles could reveal a solution In normal times, a row between the EU, the UK and a private company over the timely delivery of a contract would be of interest to few apart from the two sides’ lawyers. But these …

What can moral philosophy tell us about the Covid ‘vaccine nationalism’ row? | Alexis Papazoglou Read More »

Teesside ‘buzzing’ that Novavax vaccine will be made there

Area that has suffered industrial decline proud to play key role in fight against coronavirus Coronavirus – latest updates See all our coronavirus coverage The legend “made on Teesside” has a long and proud history, with everything from the Sydney Harbour Bridge to the Quorn in vegan sausage rolls manufactured in this industrial part of …

Teesside ‘buzzing’ that Novavax vaccine will be made there Read More »

How effective is the Novavax Covid vaccine and will it work against variants?

Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly 89% effective, with 27% of participants in the trial – …

How effective is the Novavax Covid vaccine and will it work against variants? Read More »

How effective is the Novavax Covid vaccine and will it work against variants?

Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly 89% effective, with 27% of participants in the trial – …

How effective is the Novavax Covid vaccine and will it work against variants? Read More »

Novavax Covid vaccine shown to be nearly 90% effective in UK trial

UK vaccines taskforce has bought 60m doses after study found ‘spectacular results’ Coronavirus – latest updates See all our coronavirus coverage Another vaccine against Covid, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against the UK and South African variants of the virus. The …

Novavax Covid vaccine shown to be nearly 90% effective in UK trial Read More »

EU could block millions of Covid vaccine doses from entering UK

European commission says new mechanism will give national regulators power to refuse exports Coronavirus – latest updates See all our coronavirus coverage Millions of doses of vaccines could be blocked from entering Britain from the EU within days, as part of Brussels’ response to a shortage of doses among its member states. The European commission …

EU could block millions of Covid vaccine doses from entering UK Read More »

EU health commissioner dismisses AstraZeneca contract argument – video

Brussels has refused to accept that people in the UK have first claim on Oxford/AstraZeneca doses produced in local plants. The EU’s health commissioner outright dismissed on Wednesday an argument made by Pascal Soriot, the Anglo-Swedish company’s chief executive, that he was contractually obliged to supply the UK first Britain and EU clash over claims …

EU health commissioner dismisses AstraZeneca contract argument – video Read More »

GameStop’s dizzying share price rise means it’s game over for the short-sellers | Nils Pratley

The retailer has gone from $19 to $33o thanks in part to amateurs taking on the hedge funds If you find trading bitcoin insufficiently hair-raising, try GameStop. It is the Texas-based video games retailer that will be hard to out-do as the stock market story of 2021. The share price was $19 at the start …

GameStop’s dizzying share price rise means it’s game over for the short-sellers | Nils Pratley Read More »

The EU’s vaccine bust-up with AstraZeneca is of its own making | Leo Cendrowicz

Slowness to sign up to and approve the vaccine may have caused delays, but Brussels feels the company is being less than cooperative Coronavirus – latest updates See all our coronavirus coverage Last year AstraZeneca was heralded for its pioneering vaccine discovery. Yet today the British-Swedish pharmaceutical company is embroiled in a dispute with the …

The EU’s vaccine bust-up with AstraZeneca is of its own making | Leo Cendrowicz Read More »

Head of AstraZeneca rejects calls for UK vaccine to be diverted to EU

Chief executive of pharmaceutical giant says the firm will honour UK’s earlier contract despite EU anger over shortfall Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s chief executive has insisted the UK will come first for vaccines as he rejected calls to divert doses to the European Union following a breakdown in supply. …

Head of AstraZeneca rejects calls for UK vaccine to be diverted to EU Read More »

EU means business over Covid vaccine exports, says Von der Leyen

Commission president says firms must deliver on orders after AstraZeneca warns of shortfall Coronavirus – latest updates See all our coronavirus coverage The EU “means business”, Ursula von der Leyen has said, as the bloc doubled down on plans for tighter monitoring of vaccine exports to countries outside of the union, such as the UK. …

EU means business over Covid vaccine exports, says Von der Leyen Read More »

German government challenges AstraZeneca Covid vaccine efficacy reports

Newspaper had reported that government was expecting European regulator’s assessment to show that vaccine was only 8% effective among over-65 The German government has challenged reports of a lower-than-expected efficacy rate of the AstraZeneca vaccine for older people, while reiterating concerns about the British-Swedish pharmaceutical giant’s data reporting. An article in German business daily Handelsblatt …

German government challenges AstraZeneca Covid vaccine efficacy reports Read More »

Vaccine experts call for clarity on UK’s 12-week Covid jab interval

British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place to assess the 12-week dosing interval for Covid-19 vaccines, as the row over delayed second doses continues. The UK’s coronavirus vaccination programme was shifted late last year to prioritise administering …

Vaccine experts call for clarity on UK’s 12-week Covid jab interval Read More »

Vaccine experts call for clarity on UK’s 12-week Covid jab interval

British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place to assess the 12-week dosing interval for Covid-19 vaccines, as the row over delayed second doses continues. The UK’s coronavirus vaccination programme was shifted late last year to prioritise administering …

Vaccine experts call for clarity on UK’s 12-week Covid jab interval Read More »

I’ve had my first vaccine jab. It gives me hope of liberation… but not yet

Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific achievement Coronavirus – latest updates See all our coronavirus coverage I marked a grim anniversary in an unexpected manner last week. On 18 January last year, I wrote my first …

I’ve had my first vaccine jab. It gives me hope of liberation… but not yet Read More »

Vaccine experts defend UK decision to delay second Pfizer Covid jab

Medics told they risk undermining public confidence by querying policy of three-month gap between doses Coronavirus – latest updates See all our coronavirus coverage Leading vaccine experts have backed the government’s decision to delay the second dose for up to three months, after doctors warned that the strategy was proving “ever-more difficult to justify”. The …

Vaccine experts defend UK decision to delay second Pfizer Covid jab Read More »

World’s poor need action, not Covid ‘vaccine nationalism’, say experts

Nations outbidding each other creates an ‘immoral race towards the abyss’ Coronavirus – latest updates See all our coronavirus coverage Pharmaceutical companies should do more to transfer vaccine technology to prevent the poorest countries falling behind in the distribution of Covid-19 vaccines, according to an expert. The warning came from Dag-Inge Ulstein, the co-chair of …

World’s poor need action, not Covid ‘vaccine nationalism’, say experts Read More »

MHRA and vaccine makers in talks over new Covid variants

Scientists start work on steps needed for potential rapid development of a modified vaccine, AstraZeneca says Coronavirus – latest updates See all our coronavirus coverage The UK medicines regulator is in discussions with coronavirus vaccine manufacturers about “potential modifications” that may be needed to ensure their jabs protect against new variants of the virus. The …

MHRA and vaccine makers in talks over new Covid variants Read More »

South Africa paying more than double EU price for Oxford vaccine

Health ministry quotes says premium is because government did not pay into research and development effort Coronavirus – latest updates See all our coronavirus coverage South Africa will have to buy doses of Oxford-AstraZeneca’s Covid-19 vaccine at a price nearly 2.5 times higher than most European countries, the country’s health ministry has said. The African …

South Africa paying more than double EU price for Oxford vaccine Read More »

Single Covid vaccine dose in Israel ‘less effective than we hoped’

Surge in infections dampens optimism over country’s advanced immunisation programme Coronavirus – latest updates See all our coronavirus coverage Israel’s coronavirus tsar has warned that a single dose of the Pfizer/BioNtech vaccine may be providing less protection than originally hoped, as the country reported a record 10,000 new Covid infections on Monday. In remarks reported …

Single Covid vaccine dose in Israel ‘less effective than we hoped’ Read More »

EU’s Covid vaccination debacle is down to institutional inflexibility

Supply delays underline there was no legal or economic justification for central planning A storm is raging over the EU’s failure to have ordered more of the approved Covid-19 vaccines ahead of time. Stéphane Bancel, the CEO of the US pharmaceutical company Moderna, which gained approval for its vaccine shortly after Pfizer/BioNTech, claims that the …

EU’s Covid vaccination debacle is down to institutional inflexibility Read More »

Australia’s chief medical officer defends AstraZeneca’s Covid vaccine amid efficacy concerns

Australia has secured 54m doses of the vaccine some experts say is inferior to Pfizer’s mRNA vaccine, which Australia has bought just 10m doses of Covid hotspots Victoria; NSW hotspots; Queensland hotspots NSW and Sydney trend map: where cases are rising or falling Follow the Australia coronavirus live blog Australia’s chief medical officer Professor Paul …

Australia’s chief medical officer defends AstraZeneca’s Covid vaccine amid efficacy concerns Read More »

Netanyahu touts Pfizer deal after 20% of Israelis get Covid jab

Country will share data on its rapid vaccination campaign as ‘global model’, says PM Coronavirus – latest updates See all our coronavirus coverage One in five Israelis have been given first doses of coronavirus vaccines, roughly ten times higher than the UK and US, with the country aiming to have inoculated all eligible age groups …

Netanyahu touts Pfizer deal after 20% of Israelis get Covid jab Read More »

EU plans video summit after doubling supply of Pfizer Covid vaccine

Bloc agrees deal for a further 300m doses as hopes are raised for speedier rate of inoculations Coronavirus – latest updates See all our coronavirus coverage EU leaders are to hold a pandemic video summit on 21 January after the bloc said it had reached a deal with Pfizer and BioNTech for 300m more doses …

EU plans video summit after doubling supply of Pfizer Covid vaccine Read More »

Moderna Covid vaccine approved for use by UK medicines regulator

Britain’s third jab to receive clearance for public use will not be available until the spring Coronavirus – latest updates See all our coronavirus coverage The Moderna coronavirus vaccine has been approved for use in the UK. The jab is the third to be given the green light by the Medicines and Healthcare products Regulatory …

Moderna Covid vaccine approved for use by UK medicines regulator Read More »

Third Covid vaccine set for UK approval next week but arrival delayed by Brexit

Moderna jab won’t be available in Britain until April but fourth vaccine may soon come online Coronavirus – latest updates See all our coronavirus coverage A third Covid vaccine is likely to be approved for use in Britain next week but it will not be available until April because the UK is no longer part …

Third Covid vaccine set for UK approval next week but arrival delayed by Brexit Read More »

Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty

The dire state of UK manufacturing has left us dependent on other nations. We may soon find out why some call this a ‘national security risk’ Everything now hinges on a vaccine: how many more Britons die, whether the NHS finally breaks, how long the UK stays locked down. All depends on how fast the …

Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty Read More »

UK vaccine minister vows ‘massive uplift’ in number of jabs this week

Nadhim Zahawi says ‘absolute focus’ is to get 13.9 million people inoculated by mid-February Coronavirus – latest updates See all our coronavirus coverage The UK vaccine minister, Nadhim Zahawi, has pledged a “massive uplift” in the number of coronavirus vaccinations carried out this week as he said reaching the government’s target of 13.9m jabs offered …

UK vaccine minister vows ‘massive uplift’ in number of jabs this week Read More »

No data to support UK delay of vaccines’ second dose, says WHO

Move to postpone second jab by up to 12 weeks is not supported by scientific evidence, experts find Coronavirus – latest updates See all our coronavirus coverage There is no scientific evidence for a delay of more than six weeks in administering the second dose of the Pfizer/BioNTech vaccine against Covid, say experts from the …

No data to support UK delay of vaccines’ second dose, says WHO Read More »

Analysis: is it wise for England to mix and match Covid vaccines?

US experts warn against plan to give different second jab if supplies run low Coronavirus – latest updates See all our coronavirus coverage The UK is setting the pace around the world in the approval and use of Covid vaccines but, while other countries watch intently, not all are yet prepared to embrace what looks …

Analysis: is it wise for England to mix and match Covid vaccines? Read More »

How is the Oxford Covid vaccine being deployed in England?

With jab to be administered to public for first time, we look at key questions about its rollout Coronavirus – latest updates See all our coronavirus coverage The biggest vaccination programme in the UK’s history will receive a major boost on Monday, with the first use of the Oxford/AstraZeneca Covid vaccine. We answer some key …

How is the Oxford Covid vaccine being deployed in England? Read More »

The Oxford Covid jab is delivered this week. But when will vaccines bring results?

Fall or rise in coronavirus cases will not initially be a good measure of efficacy, say scientists devising ways to audit progress Why is Britain delaying second doses of vaccine? Coronavirus – latest updates See all our coronavirus coverage People in Britain are set to get their first shots of the Oxford/AstraZeneca vaccine on Monday, …

The Oxford Covid jab is delivered this week. But when will vaccines bring results? Read More »

What difference will Oxford/AstraZeneca vaccine make in UK?

We look at how the introduction of a new vaccine in the fight against Covid will work Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine is central to the government’s plans for ending social distancing in the UK and returning to some sort of normality. It has invested in seven different …

What difference will Oxford/AstraZeneca vaccine make in UK? Read More »

Change in vaccine policy is a high-stakes gamble | Letters

The effectiveness of delaying the second dose of Covid vaccines must be carefully monitored, argues Dr Grizelda George, while Jan Mortimer and Jenny van Tinteren fear the move will increase distrust and uncertainty The manufacturer of the Pfizer/BioNTech vaccine has said its efficacy has only been assessed for two doses given three weeks apart. Therefore …

Change in vaccine policy is a high-stakes gamble | Letters Read More »

BioNTech criticises EU failure to order enough Covid vaccine

Firm races to fill potential gap left by bloc’s gamble on several vaccines being approved Coronavirus – latest updates See all our coronavirus coverage BioNtech has criticised the EU’s failure to order more doses of its coronavirus vaccine, saying it is now racing with its US partner Pfizer to boost production amid fears of a …

BioNTech criticises EU failure to order enough Covid vaccine Read More »

Questions hang over UK’s rollout of Oxford/AstraZeneca jab

Analysis: regulator surprises by approving 12-week gap between first and second shots of vaccine as well as Pfizer/BioNTech shot Coronavirus – latest updates See all our coronavirus coverage It’s a pragmatic solution to an incredibly urgent problem – how to immunise very large numbers of people at risk from a rampaging variant of Covid-19 in …

Questions hang over UK’s rollout of Oxford/AstraZeneca jab Read More »

‘Happy vaccine day’ at Welsh factory proudly preparing Oxford doses

Staff at Wockhardt in Wrexham buzzing at news of approval after working over Christmas Most of the sprawling industrial estate on the edge of Wrexham was quiet. There was little sign of activity at the engineering firms or in the self-storage units or greasy spoon cafes. But behind the wire fence of the Wockhardt UK …

‘Happy vaccine day’ at Welsh factory proudly preparing Oxford doses Read More »

NHS doctors ‘scrabbling’ to get vaccine amid alarm at Covid variant

Many medics ‘frustrated’ about low priority given to frontline staff at high risk of infection Coronavirus – latest updates See all our coronavirus coverage Frontline NHS staff have been denied the Pfizer/BioNTech vaccine, leaving doctors alarmed and “scrabbling” to get immunised. A new survey reveals that almost two-thirds of medics who responded to it have …

NHS doctors ‘scrabbling’ to get vaccine amid alarm at Covid variant Read More »

Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers

Pharmaceutical companies complain of breach of confidentiality after amount EU has agreed to pay for leading vaccines goes public Coronavirus – latest updates See all our coronavirus coverage A Belgian minister has inadvertently blown the lid off a sensitive and commercial secret – the price that the EU has agreed to pay for the leading …

Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers Read More »

Scheme to get Covid vaccine to poorer countries at ‘high risk’ of failure

Risk assessment documents say cost, delays and shortages could lead to billions not vaccinated until 2024 Coronavirus – latest updates See all our coronavirus coverage The global scheme to deliver Covid-19 vaccines to poorer countries faces a “very high” risk of failure, potentially leaving billions of people with no access to vaccines until as late …

Scheme to get Covid vaccine to poorer countries at ‘high risk’ of failure Read More »

Tensions mount over handling of UK Covid vaccine rollout

With overall costs for vaccinating the UK population at £12bn, the public accounts committee flags ‘highly unusual’ arrangements Coronavirus – latest updates See all our coronavirus coverage Vaccinating the population against Covid-19 will cost up to £12bn, Whitehall’s spending watchdog has disclosed, amid details of tensions between health bodies over the rollout. The National Audit …

Tensions mount over handling of UK Covid vaccine rollout Read More »

GSK/Sanofi Covid vaccine delayed until end of next year

Trials reveal vaccine failed to produce a strong immune response in older people Coronavirus – latest updates See all our coronavirus coverage A coronavirus vaccine being developed by GlaxoSmithKline and its French partner, Sanofi, will be delayed until the end of next year after trials revealed it failed to produce a strong immune response in …

GSK/Sanofi Covid vaccine delayed until end of next year Read More »

Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi

The challenge of delivering vaccines on this scale are hard, but are firmly within the world of logistics, engineering, and politics Coronavirus – latest updates See all our coronavirus coverage The UK has become the first country to approve one of the coronavirus vaccines that the entire world has been desperately waiting for. And on …

Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi Read More »

Hackers accessed vaccine documents in cyber-attack on EMA

Papers relating to Pfizer/BioNTech vaccine reportedly targeted in attack on European Medicines Agency German biotech firm BioNTech said on Wednesday that regulation documents related to the Covid-19 vaccine it has developed with Pfizer were “unlawfully accessed” after a cyber-attack on Europe’s medicines regulator. Earlier, the European Medicines Agency (EMA) – which is responsible for assessing …

Hackers accessed vaccine documents in cyber-attack on EMA Read More »

Nine out of 10 in poor nations to miss out on inoculation as west buys up Covid vaccines

Billions unlikely to get jabs as rich countries secure 53% of most promising vaccines Coronavirus – latest updates See all our coronavirus coverage Nine out of 10 people in 70 low-income countries are unlikely to be vaccinated against Covid-19 next year because the majority of the most promising vaccines coming on-stream have been bought up …

Nine out of 10 in poor nations to miss out on inoculation as west buys up Covid vaccines Read More »

Covid vaccine arrives in UK hospitals ready for first jabs

Medical director warns of great hurdles in largest vaccination campaign in UK history Coronavirus – latest updates See all our coronavirus coverage Batches of the Covid vaccine have begun to arrive in hospitals around the UK, ready for the first jabs on Tuesday in what NHS England’s medical director warned would be the largest and …

Covid vaccine arrives in UK hospitals ready for first jabs Read More »

Covid-19 vaccine ‘very safe and highly effective’, UK health chief says

Vaccine safety message ‘vitally important’, head of medicines regulator tells Andrew Marr Show Coronavirus – latest updates See all our coronavirus coverage Public health messaging that people can have faith in the safety of coronavirus vaccines is “vitally important”, the leader of the body that has approved the Pfizer jab has said. Dr June Raine, …

Covid-19 vaccine ‘very safe and highly effective’, UK health chief says Read More »

The vaccine miracle: how scientists waged the battle against Covid-19

We trace the extraordinary research effort, from the discovery of the virus’s structure to the start of inoculations this week Coronavirus – latest updates See all our coronavirus coverage In the early afternoon of 3 January this year, a small metal box was delivered to the Shanghai Public Health Clinical Centre addressed to virus expert …

The vaccine miracle: how scientists waged the battle against Covid-19 Read More »

Oxford controversy is the first shot in international battle over vaccine efficiency

Trials will not reveal all the facts on prevention for each new drug – that process could last for years Coronavirus – latest updates See all our coronavirus coverage In a few days, researchers plan to solve a medical mystery that threatens to erupt into a major transatlantic battle. Scientists at Oxford University say they …

Oxford controversy is the first shot in international battle over vaccine efficiency Read More »

Different age groups may get different Covid vaccines, experts say

Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older people Coronavirus – latest updates See all our coronavirus coverage Concerns around the efficacy of the Oxford University/AstraZeneca coronavirus jab in older people could lead to different age groups being given different vaccines, experts have said. The partners announced last …

Different age groups may get different Covid vaccines, experts say Read More »

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn

Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the development of a new type of vaccine to combat Covid-19. After testing tens of thousands of people, BioNTech’s vaccine has been shown to be 95% effective in providing protection for …

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn Read More »

Will everyone in the world have access to a Covid vaccine? – video explainer

The hunt for a coronavirus vaccine is showing promise but it is premature to say the end of the pandemic is nigh. Several rich countries have signed a ‘frenzy of deals’ that could prevent many poor nations from getting access to immunisation until at least 2024. Also, many drug firms are potentially refusing to waive patents and other intellectual property rights …

Will everyone in the world have access to a Covid vaccine? – video explainer Read More »

Here’s how to tackle the Covid-19 anti-vaxxers | Will Hanmer-Lloyd

Do not demonise. To optimise the vaccine rollout, all of us must show respect to those who are unsure about inoculations Will Hanmer-Lloyd is a behavioural strategist The Covid-19 vaccines, which are up to 95% effective, have the potential to save millions of lives in the UK and many more around the world. Yet creating …

Here’s how to tackle the Covid-19 anti-vaxxers | Will Hanmer-Lloyd Read More »

A vaccine revolution | podcast

Results from clinical trials have shown that the world has three apparently highly effective vaccines for Covid-19. With the race now on for regulatory approval, production and distribution, is the end of the pandemic within reach? After a gruelling year of successive waves of Covid-19 infections and national lockdowns there has been a burst of …

A vaccine revolution | podcast Read More »

Vaccine results bring us a step closer to ending Covid, says Oxford scientist

Latest breakthrough comes as PM says he hopes most at-risk could be immunised by Easter Coronavirus – latest updates See all our coronavirus coverage The world is moving a step closer to ending the coronavirus pandemic, the scientist behind Britain’s first vaccine has declared, as Boris Johnson said he hoped the majority of those most …

Vaccine results bring us a step closer to ending Covid, says Oxford scientist Read More »

Oxford/AstraZeneca vaccine ‘likely first to be widely used in UK’

Experts say Pfizer/BioNTech product faces more logistical challenges and obstacles Coronavirus – latest updates See all our coronavirus coverage The Oxford vaccine is likely to be the first Covid jab that large numbers of Britons receive, despite Pfizer’s candidate already being analysed by the medicines regulators, experts say. The fact that the Oxford vaccine can …

Oxford/AstraZeneca vaccine ‘likely first to be widely used in UK’ Read More »

‘It’s a great day’: Oxford coronavirus vaccine volunteers on trial data

Trial participants react to news that Oxford AstraZeneca Covid vaccine has up to 90% efficacy Coronavirus – latest updates See all our coronavirus coverage Dan McAteer describes his reaction more as a sense of relief than elation when his phone pinged on Monday morning with a push alert reporting that the Oxford AstraZeneca vaccine has …

‘It’s a great day’: Oxford coronavirus vaccine volunteers on trial data Read More »

Oxford AstraZeneca results open up Covid vaccine to developing countries

Jab can be kept in fridge and is part of global initiative to distribute doses at limited cost Coronavirus – latest updates See all our coronavirus coverage The efficacy of the Oxford University/AstraZeneca vaccine opens the way for a cheap and more easily transportable vaccine to be made available to some of the world’s poorest …

Oxford AstraZeneca results open up Covid vaccine to developing countries Read More »

The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial

Plans for mass immunisation against Covid-19 are developing fast, but concerns must be addressed In the 1960s, academics studying rumours drew inspiration from epidemiology. They noted how such stories spread through communities, “infecting” some individuals while others seemed immune, and how more resistant populations could stop their spread. Their insights have in turn been taken …

The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial Read More »

Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn

No one knew whether mRNA technology would work against this virus – but it does. It’s an extraordinary moment for science Coronavirus – latest updates See all our coronavirus coverage The past few months have brought a number of scientific terms to public attention. We’ve had to digest R (a virus’s reproduction number) and PCR …

Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn Read More »

Trials to begin in UK for Covid antibody cocktail drug treatment

Scientists say jab could be used to protect those who cannot be given vaccines Coronavirus – latest updates See all our coronavirus coverage Major trials will begin this weekend of an antibody cocktail that scientists hope will protect people against Covid-19 and could be swiftly used in care homes or on cruise ships in the …

Trials to begin in UK for Covid antibody cocktail drug treatment Read More »

First Americans may get Covid vaccine in December if US approves Pfizer request

Pharmaceutical partners submitted bid to the FDA for vaccine to be reviewed and emergency authorization may occur within weeks It could take as little as three weeks for US regulators to approve Pfizer and partner BioNTech’s emergency authorization request for their Covid-19 vaccine – with the first Americans being offered the first inoculation outside clinical …

First Americans may get Covid vaccine in December if US approves Pfizer request Read More »

UK faces calls to drop opposition to patent-free Covid vaccines

Request will be made at WTO meeting in order to allow mass production of treatments Coronavirus – latest updates See all our coronavirus coverage The UK will be asked to reconsider its opposition to waiving intellectual property rights for Covid-19 vaccines and treatments at a World Trade Organization meeting on Friday, a move that would …

UK faces calls to drop opposition to patent-free Covid vaccines Read More »

Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows

Among first 170 Covid cases in trial, eight had received vaccine and 162 were in placebo group Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine against Covid-19 performs even better than previously thought, with 95% efficacy, equalling the early results from Moderna on Monday, according to an analysis of the final …

Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows Read More »

Moderna vaccine’s effectiveness bodes well for Oxford/AstraZeneca jab

Phase 3 success rate of 95% for US firm’s treatment is promising for UK vaccine trial Coronavirus – latest updates See all our coronavirus coverage Hopes are rising for the Covid jab being developed by Oxford University, after Moderna became the second company to reveal impressive results from its vaccine trials. Interim results from phase …

Moderna vaccine’s effectiveness bodes well for Oxford/AstraZeneca jab Read More »

It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff

To make vaccination work, we must reach out to the naturally cautious – a bigger proportion than you might assume Coronavirus – latest updates See all our coronavirus coverage Lydia Guthrie is not very daring by nature. A psychotherapist and mother of two from Oxford, she couldn’t be persuaded into bungee jumping for all the …

It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff Read More »

Moderna Covid vaccine candidate almost 95% effective, trials show

US-based biotech firm is latest to reveal impressive results from phase 3 trials of jab Coronavirus – latest updates See all our coronavirus coverage The race for a coronavirus vaccine has received another shot in the arm with the US biotech firm Moderna becoming the latest to reveal impressive results from phase 3 trials of …

Moderna Covid vaccine candidate almost 95% effective, trials show Read More »

BioNTech vaccine scientist says jab could halve Covid transmission

Uğur Şahin ‘very confident’ vaccine candidate developed with Pfizer will cause big reduction in cases Coronavirus – latest updates See all our coronavirus coverage The scientist behind the first potential Covid-19 vaccine to clear interim clinical trials says he is “very confident” the jab will reduce transmission of the disease, perhaps by 50%, resulting in …

BioNTech vaccine scientist says jab could halve Covid transmission Read More »

Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik

Better to build social solidarity than to dismiss reluctance to be immunised as ignorance Coronavirus – latest updates See all our coronavirus coverage “If a strain as deadly as the 1918 influenza emerges and people’s hesitancy to get vaccinated remains at the level it is today, a debilitating and fatal disease will spread.” So wrote …

Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik Read More »

Speedy work on Covid gives the vaccine industry a shot in the arm

Pfizer was first with the news, but biotech firms, governments, banks and NGOs are all involved in the search for a jab to prevent coronavirus infectionThe leading candidate to become the world’s first Covid-19 vaccine, developed by the US pharmaceutical company Pfizer and Germany’s BioNTech, had its genesis in late January 2020. Uğur Şahin, chief …

Speedy work on Covid gives the vaccine industry a shot in the arm Read More »

BioNTech chief rejects Trump claim it delayed Covid vaccine news

Exclusive: Ugur Şahin says he and Pfizer CEO received results night before announcement Coronavirus – latest updates See all our coronavirus coverage The scientist behind the BioNTech/Pfizer coronavirus vaccine has defended his company from Donald Trump’s accusation that it deliberately delayed news of its rapid progress until after the election, saying “we don’t play politics”. …

BioNTech chief rejects Trump claim it delayed Covid vaccine news Read More »

Scientist behind BioNTech/Pfizer vaccine says it can end pandemic

Exclusive: BioNTech’s CEO Uğur Şahin says he is confident vaccine can ‘bash the virus over the head’ Coronavirus – latest updates See all our coronavirus coverage The scientist behind the first Covid-19 vaccine to clear interim clinical trials says he is confident his product can “bash the virus over the head” and put an end …

Scientist behind BioNTech/Pfizer vaccine says it can end pandemic Read More »